Citius Oncology (CTOR) Shares Outstanding (Diluted) (2022 - 2026)
Citius Oncology (CTOR) reported Shares Outstanding (Diluted) of 107.89 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 50.8% from 71.55 million a year earlier and up 7.9% from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Citius Oncology posted Shares Outstanding (Diluted) of 73.27 million, up 7.7% from FY2024.
- Shares Outstanding (Diluted) has a three-year compound annual growth rate of 183.7% (FY2022 to FY2025).
- By fiscal year, Shares Outstanding (Diluted) came in at 68.05 million in FY2024, 67.5 million in FY2023 and 3.21 million in FY2022.
- The fiscal Q3 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q4 2022.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last four quarters, with growth averaging 30.1% over the last four quarters.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at 100.03 million (Q2 2026), 87.46 million (Q1 2026) and 73.27 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Citius Oncology | 106.82 Mn | 106.82 Mn | 1.00 Mn | 107.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.89 Mn |
| Mar 31, 2026 | 100.03 Mn |
| Dec 31, 2025 | 87.46 Mn |
| Sep 30, 2025 | 73.27 Mn |
| Jun 30, 2025 | 71.55 Mn |
| Mar 31, 2025 | 71.55 Mn |
| Dec 31, 2024 | 71.55 Mn |
| Sep 30, 2024 | 68.05 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 67.50 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | 9.02 Mn |
| Mar 31, 2023 | 9.02 Mn |
| Dec 31, 2022 | 3.21 Mn |
API Access
Citius Oncology Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();